Clips on 'sglt2 inhibitors'

Follow

SGL2-T Inhibitors Reduce Death Risk in Patients With Heart Failure

2:40 · AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins - Peter Attiaview episode

The Peter Attia Drive

1

Canagliflozin Is an SGLT-2 Inhibitor; When Combined With Metformin, It Potently Lowers HbA1c

3:18 · AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins - Peter Attiaview episode

The Peter Attia Drive

0

High Glucose Reduces BHB's Impact on NLRP3 Inflammasome Formation

1:21 · How Low Glucose & Ketones Benefit Your Immune System w/ Brianna Stubbs, PhDview episode

High Intensity Health Radio with Mike Mutzel, MS

0

Giving Diabetics Excess Insulin Covers the Root Problem & Makes Things Worse

7:08 · Jason Fung, M.D.: Fasting as a potent antidote to obesity, insulin resistance, type 2 diabetes, and the many symptoms of metabolic illness - Dr. Jason Fungview episode

The Peter Attia Drive

glucose insulin brain drugs

···

1

Canagliflozin, an SGLT2 Inhibitor, Blunts the Reabsorption of Glucose

5:03 · #517: Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pullview episode

The Tim Ferriss Show

0

Topic: sglt2-inhibitors

SGL2-T Inhibitors Reduce Death Risk in Patients With Heart Failure

SGL2-T Inhibitors Reduce Death Risk in Patients With Heart Failure

AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins - Peter Attia

0:00

2:40

0:00

2:40

SGL2-T Inhibitors Reduce Death Risk in Patients With Heart Failure

AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins

AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins - Peter Attia

1 of 5

AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins - Peter Attia

1

+

1.0

-

+

1.0

-

0

ms